Jason Williams, MD | Authors

Articles

Rationalizing the Study of Intratumoral Immunotherapy in Breast Cancer Origin Liver Metastases

February 05, 2020

Jason Williams, MD, the director of Interventional Oncology and Immunotherapy oncologist at the Williams Cancer Institute, discusses a study in which an immunotherapy combination was administered intratumorally to patients with liver metastases linked to breast cancer, which he presented in a poster at the 2019 Society of Immunotherapy of Cancer Annual Meeting.